Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Standardization of Management of Warm Autoimmune Hemolytic Anemia

Nithin Thomas, M Luisa Bowzard, Laura Sun, Jacqueline Comiter, Manila Gaddh

Blood (2024) 144 (Supplement 1): 7565.

https://doi.org/10.1182/blood-2024-208597

Published: 2024

Journal Articles

Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

Rishabh Singh, Ishan J Tatake, Joseph Sibley, Radhika Gangaraju, Karlyn A. Martin, Rachel P. Rosovsky, Diana Marie Byrnes, Ming Y Lim, Manila Gaddh, Jacob Cogan, Kimberley Youkhana, Lisa Baumann Kreuziger, Andrew M. Peseski

Blood (2024) 144 (Supplement 1): 7549.

https://doi.org/10.1182/blood-2024-193712

Published: 2024

Journal Articles

Comparative Analysis of Perioperative Anticoagulation Management Guidelines across U.S. Institutions

Rishabh Singh, Jacob Cogan, Caroline Cromwell, Manila Gaddh, Radhika Gangaraju, Ming Y Lim, Colleen T. Morton, Andrew M. Peseski, Rachel P. Rosovsky, Ishan J Tatake, Kimberley Youkhana, Lisa Baumann Kreuziger

Blood (2024) 144 (Supplement 1): 5014.

https://doi.org/10.1182/blood-2024-202116

Published: 2024

Journal Articles

Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen

Barbara Simon, Andrea Ceglédi, János Dolgos, Péter Farkas, Manila Gaddh, László Hankó, Robert Horváth, Ambrus Kaposi, Lászlóné Magyar, Tamás Masszi, Attila Szederjesi, Nikolett Wohner, Imre Bodó

Blood (2022) 140 (18): 1983–1992.

https://doi.org/10.1182/blood.2022016873

Published: 2022

Includes: Supplemental data

Journal Articles

Comparative Analysis of Direct Oral Anticoagulants and Vitamin K Antagonists in Antiphospholipid Syndrome Patients

Maha AT Elsebaie, Zoe Alexandra Wickham, Stephanie Debragga, Juan Li, Manila Gaddh

Blood (2021) 138 (Supplement 1): 2135.

https://doi.org/10.1182/blood-2021-147986

Published: 2021

Journal Articles

Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Damon E. Houghton, MDMS, Henny Heisler H. Billett, MD, Manila Gaddh, MD, Oluwatomiloba Onadeko, MBBS, Gemlyn George, MD, Tzu-Fei Wang, MD MPH, Thein H. Oo, MD, Yuanyue Sun, MD, Mingen Feng, MS, Michael Jaglal, MD, Michael B. Streiff, MD, Pippa Simpson, PhD, Radhika Gali, MD, Lisa Baumann Kreuziger, MD MS

Blood (2019) 134 (Supplement_1): 325.

https://doi.org/10.1182/blood-2019-124139

Published: 2019

Journal Articles

Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Lisa Baumann Kreuziger, MD MS, Manila Gaddh, MD, Oluwatomiloba Onadeko, MBBS, Gemlyn George, MD, Tzu-Fei Wang, MD, Thein H. Oo, MD, Ming Feng, Pippa Simpson, PhD, Radhika Gali, MD, Henny Heisler Billett, MD

Blood (2018) 132 (Supplement 1): 1248.

https://doi.org/10.1182/blood-2018-99-112206

Published: 2018

Journal Articles

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Blood (2017) 130 (Supplement 1): 5667.

https://doi.org/10.1182/blood.V130.Suppl_1.5667.5667

Published: 2017

Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)

Jee Hyun Kong, Elliott F. Winton, MD, Leonard Heffner, MD, Manila Gaddh, MD, Brittany Hill, PA-C, MMSc, MSc, MPH, Martha L. Arellano, MD, Fuad El-Rassi, Audrey Kim, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5247.

https://doi.org/10.1182/blood.V130.Suppl_1.5247.5247

Published: 2017

Journal Articles

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

Azra Raza, MD, Aref Al-Kali, MD, Raoul Tibes, MD PhD, Gary Spitzer, MD, Manila Gaddh, MD, Benjamin Tycko, MD PhD, Sangmin Lee, MD, Naomi Galili, PhD, Abdullah Mahmood Ali, PhD, John G. Mears, MD, Siddhartha Mukherjee, MD PhD, Ryan Shelton, BS, Steven M. Fruchtman, MD, Michael E. Petrone, MD MPH, Patrick S. Zbyszewski, MBA, Mark Lawrence Heaney, MD PhD

Blood (2017) 130 (Supplement 1): 1689.

https://doi.org/10.1182/blood.V130.Suppl_1.1689.1689

Published: 2017

Journal Articles

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

Jee Hyun Kong, Elliott F. Winton, MD, Leonard Heffner, MD, Manila Gaddh, MD, Brittany Hill, PA-C, MMSc, MSc, MPH, Martha Arellano, MD, Fuad El-Rassi, Audrey Kim, Anand Jillella, MD, Vamsi K Kota

Blood (2017) 130 (Supplement 1): 1607.

https://doi.org/10.1182/blood.V130.Suppl_1.1607.1607

Published: 2017

Journal Articles

Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients

Zakaria Almuwaqqat, MD, Manila Gaddh, MD, Danielle Schlafer, Pharm D, BCOP, Don Hutcherson, RPh, Martha L. Arellano, MD, Susmita Parashar, MD MPH, MS, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5025.

https://doi.org/10.1182/blood.V130.Suppl_1.5025.5025

Published: 2017

Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 2793.

https://doi.org/10.1182/blood.V128.22.2793.2793

Published: 2016

Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

Jee Hyun Kong, MD, Hanna Jean Khoury, MD, Elliott F. Winton, MD, Leonard T. Heffner, MD, Manila Gaddh, MD, Martha Arellano, MD, Fuad El-Rassi, MD, Audrey S Kim, RN, Anand Jillella, MD, Imre Bodó, MDPhD, Vamsi Kota, MD

Blood (2016) 128 (22): 3093.

https://doi.org/10.1182/blood.V128.22.3093.3093

Published: 2016

Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 1622.

https://doi.org/10.1182/blood.V128.22.1622.1622

Published: 2016

Journal Articles

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

Simon B. Zeichner, D.O., Shannon Gleason, M.L.S., Ana G. Antun, MD, Amelia Langston, MD, Leonard T Heffner, Jr., MD, Vamsi K Kota, MD, Manila Gaddh, MD, Martha Arellano, MD

Blood (2015) 126 (23): 4955.

https://doi.org/10.1182/blood.V126.23.4955.4955

Published: 2015

Journal Articles

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Anand Jillella, MD, Martha Arellano, MD, Asad Bashey, MD PhD, Sarah I. Vidito, DO, Robert K. Stuart, MD, Caleb Leung, Kaitlin Sitchenko, Manila Gaddh, MD, Leonard T Heffner, Jr., MD, Ravindra B. Kolhe, MD PhD, Jacques Galipeau, MD, Amelia Langston, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 3779.

https://doi.org/10.1182/blood.V126.23.3779.3779

Published: 2015

Journal Articles

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Tareq Braik, MD, Dayra Avila, MD, Shivi Jain, MD, Manila Gaddh, MD, Barabara Yim, PharmD, Peter Ruestow, MPH, Shylendra B Sreenivasappa, MD, Shweta Gupta, MD, Sylvia Velinova, MD, Paul G. Rubinstein, MD, Margaret Telfer, MD, Mousami Shah, MD, Thomas Lad, Rosalind Catchatourian, MD

Blood (2011) 118 (21): 5118.

https://doi.org/10.1182/blood.V118.21.5118.5118

Published: 2011

Journal Articles

Clinical Significance of Positive Red Blood Cell Antibody Screen with Inconclusive Antibody Identification

Shweta Gupta, MD, Prantesh Jain, MD, Harsha v Poola, MD, Sumedha Dhar, MD, Manila Gaddh, MD, Paul G. Rubinstein, MD, Tareq Braik, MD, Rosalind Catchatourian, MD, Margaret Clare Telfer, MD, FACP, Ram Kakaiya, MD

Blood (2011) 118 (21): 4340.

https://doi.org/10.1182/blood.V118.21.4340.4340

Published: 2011

Journal Articles

A Three Year Experience at An Inner City Safety-Net Hospital with Immune Thrombocytopenic Purpura (ITP)

Harsha V Poola, MD, Manila Gaddh, MD, Samuel N. Ofori, MD, Moushmi Shah, MD, Mohammed A. Kassem, MD, Augustin Haidau, MD, Rosalind Catchatourian, MD, Margaret Telfer, MD

Blood (2010) 116 (21): 4684.

https://doi.org/10.1182/blood.V116.21.4684.4684

Published: 2010

NARROW

Standardization of Management of Warm Autoimmune Hemolytic Anemia

Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

Comparative Analysis of Perioperative Anticoagulation Management Guidelines across U.S. Institutions

Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen

Comparative Analysis of Direct Oral Anticoagulants and Vitamin K Antagonists in Antiphospholipid Syndrome Patients

Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Clinical Significance of Positive Red Blood Cell Antibody Screen with Inconclusive Antibody Identification

A Three Year Experience at An Inner City Safety-Net Hospital with Immune Thrombocytopenic Purpura (ITP)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only